Costs and cost effectiveness of health checks conducted by nurses in primary care: the Oxcheck study
- PMID: 8634616
- PMCID: PMC2351075
- DOI: 10.1136/bmj.312.7041.1265
Costs and cost effectiveness of health checks conducted by nurses in primary care: the Oxcheck study
Abstract
Objective: To measure the costs and cost effectiveness of the Oxcheck cardiovascular risk factor screening and intervention programme.
Design: Cost effectiveness analysis of a randomised controlled trial using clinical and economic data taken from the trial.
Setting: Five general practices in Luton and Dunstable, England.
Subjects: 2205 patients who attended a health check in 1989-90 and were scheduled for re-examination in 1992-3 (intervention group); 1916 patients who attended their initial health check in 1992-3 (control group). Participants were men and women aged 35-64 years.
Intervention: Health check conducted by nurse, with health education and follow up according to degree of risk.
Main outcome measures: Cost of health check programme; cost per 1% reduction in coronary risk.
Results: Health check and follow up cost 29.27 pounds per patient. Estimated programme cost per 1% reduction in coronary risk per participant was between 1.46 pounds and 2.25 pounds; it was nearly twice as much for men as women.
Conclusions: The cost to the practice of implementing Oxcheck-style health checks in an average sized practice of 7500 patients would be 47,000 pounds, a proportion of which could be paid for through staff pay reimbursements and Band Three health promotion target payments. This study highlights the considerable difficulties faced when calculating the costs and benefits of a health promotion programme. Economic evaluations should be integrated into the protocols of randomised controlled trials to enable judgments to be made on the relative cost effectiveness of different prevention strategies.
Comment in
-
What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses.BMJ. 1996 May 18;312(7041):1274-8. doi: 10.1136/bmj.312.7041.1274. BMJ. 1996. PMID: 8634618 Free PMC article.
-
Secondary prevention of coronary heart disease in primary care is cost effective.BMJ. 1996 Aug 31;313(7056):563. doi: 10.1136/bmj.313.7056.563. BMJ. 1996. PMID: 8790013 Free PMC article. Clinical Trial. No abstract available.
-
Cost effectiveness of health checks. Effect of intervention was sustained.BMJ. 1996 Sep 7;313(7057):624. doi: 10.1136/bmj.313.7057.624. BMJ. 1996. PMID: 8806264 Free PMC article. Clinical Trial. No abstract available.
Similar articles
-
Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.BMJ. 1996 May 18;312(7041):1269-73. doi: 10.1136/bmj.312.7041.1269. BMJ. 1996. PMID: 8634617 Free PMC article.
-
What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses.BMJ. 1996 May 18;312(7041):1274-8. doi: 10.1136/bmj.312.7041.1274. BMJ. 1996. PMID: 8634618 Free PMC article.
-
Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. Imperial Cancer Research Fund OXCHECK Study Group.BMJ. 1994 Jan 29;308(6924):308-12. BMJ. 1994. PMID: 8124120 Free PMC article. Clinical Trial.
-
General Health Checks in Adult Primary Care: A Review.JAMA. 2021 Jun 8;325(22):2294-2306. doi: 10.1001/jama.2021.6524. JAMA. 2021. PMID: 34100866 Review.
-
Cost effectiveness of cardiovascular disease prevention strategies: a perspective on EU food based dietary guidelines.Public Health Nutr. 2001 Apr;4(2B):711-5. doi: 10.1079/phn2001161. Public Health Nutr. 2001. PMID: 11683566 Review.
Cited by
-
Secondary prevention of coronary heart disease in primary care is cost effective.BMJ. 1996 Aug 31;313(7056):563. doi: 10.1136/bmj.313.7056.563. BMJ. 1996. PMID: 8790013 Free PMC article. Clinical Trial. No abstract available.
-
Cost effectiveness of health checks. Effect of intervention was sustained.BMJ. 1996 Sep 7;313(7057):624. doi: 10.1136/bmj.313.7057.624. BMJ. 1996. PMID: 8806264 Free PMC article. Clinical Trial. No abstract available.
-
Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31.Gut. 2003 Aug;52(8):1133-9. doi: 10.1136/gut.52.8.1133. Gut. 2003. PMID: 12865271 Free PMC article.
-
Families of patients with premature coronary heart disease: an obvious but neglected target for primary prevention.BMJ. 2007 Sep 8;335(7618):481-5. doi: 10.1136/bmj.39253.577859.BE. BMJ. 2007. PMID: 17823190 Free PMC article. Review.
-
Simvastatin. A reappraisal of its cost effectiveness in dyslipidaemia and coronary heart disease.Pharmacoeconomics. 1997 Jan;11(1):89-110. doi: 10.2165/00019053-199711010-00010. Pharmacoeconomics. 1997. PMID: 10172918 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources